|Articles|October 16, 2015

Opportunity for Public Comment on Revisions to USP 797 Pharmaceutical Compounding

On Sept. 25, 2015, the U.S. Pharmacopeial Convention (USP) Compounding Expert Committee pre-posted revisions to General Chapter 797 Pharmaceutical Compounding – Sterile Preparations for public comment. The purpose of these revisions is to clarify requirements, reflect stakeholder feedback, and incorporate new information. The proposed revisions will be published for public comment in Pharmacopeial Forum (PF) 41(6) [Nov.–Dec. 2015] on Nov. 2, 2015.

The USP will hold an open microphone web meeting on Wednesday, Oct. 21, 2015 at 2 p.m. ET to discuss the proposed revisions.

More information about the proposed revisions and how to submit public comments can be found on the USP website.

The proposed revisions with line numbers can be viewed

.

Registration information for the open microphone meeting can be found here.

Source: CDC


Related to this article

Infection preventionists in full PPE with children in DRC.  (Image credit: author with AI)
Nearly 4 months into the DRC's Bundibugyo virus disease outbreak, some indicators suggest transmission may be slowing. But shifting hotspots, treatment-center capacity problems, community deaths, and incomplete surveillance data show why national case totals alone cannot determine whether containment has been achieved.